Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSI
4551
PUT
DELISTED
Vitamin Shoppe Inc.
VSI
| $155K | ﹤0.01% |
29,000
+28,800
| +14,400% | +$222K |
|
|
CY
4552
DELISTED
Cypress Semiconductor
CY
| $155K | ﹤0.01% |
10,250
-307,048
| -97% | -$4.3M |
|
4553
PUT
Icahn Enterprises
IEP
$5.09B
| $154K | ﹤0.01% |
2,800
-9,700
| -78% | -$510K |
|
4554
CALL
Medifast
MED
$136M
| $154K | ﹤0.01% |
+2,600
| New | +$129K |
|
4555
Vermilion Energy
VET
$1.66B
| $154K | ﹤0.01% |
4,322
+4,222
| +4,222% | +$139K |
|
4556
CALL
Automatic Data Processing
ADP
$109B
| $153K | ﹤0.01% |
1,400
-9,700
| -87% | -$1.04M |
|
|
HEPA
4557
DELISTED
Hepion Pharmaceuticals
HEPA
| $153K | ﹤0.01% |
1
| – | – |
|
|
ARAV
4558
PUT
DELISTED
Aravive, Inc. Common Stock
ARAV
| $153K | ﹤0.01% |
+10,383
| New | +$1.05M |
|
|
AVTA
4559
DELISTED
Avantax, Inc. Common Stock
AVTA
| $153K | ﹤0.01% |
6,077
-10,295
| -63% | -$233K |
|
|
AMRN
4560
CALL
Amarin Corp
AMRN
$303M
| $152K | ﹤0.01% |
2,165
+1,505
| +228% | +$107K |
|
4561
PUT
Caesarstone
CSTE
$74M
| $152K | ﹤0.01% |
5,100
+5,000
| +5,000% | +$156K |
|
4562
Enerpac Tool Group
EPAC
$1.92B
| $152K | ﹤0.01% |
5,991
-8,318
| -58% | -$203K |
|
4563
Texas Roadhouse
TXRH
$13.8B
| $152K | ﹤0.01% |
3,094
-698
| -18% | -$34K |
|
|
FLG
4564
PUT
Flagstar Bank National Association
FLG
$5.93B
| $152K | ﹤0.01% |
3,933
+2,333
| +146% | +$88K |
|
4565
FB Financial Corp
FBK
$3.04B
| $151K | ﹤0.01% |
4,003
-4,102
| -51% | -$143K |
|
4566
Sony
SONY
$135B
| $151K | ﹤0.01% |
20,160
-145,440
| -88% | -$1.14M |
|
|
GMS
4567
DELISTED
GMS Inc
GMS
| $150K | ﹤0.01% |
4,215
-42,064
| -91% | -$1.3M |
|
4568
Hecla Mining
HL
$10.7B
| $150K | ﹤0.01% |
29,912
-221,934
| -88% | -$1.14M |
|
|
RRTS
4569
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $150K | ﹤0.01% |
630
+482
| +326% | +$88.6K |
|
4570
CorVel
CRVL
$3.12B
| $149K | ﹤0.01% |
8,193
-3,141
| -28% | -$52.4K |
|
4571
PUT
Dell
DELL
$287B
| $149K | ﹤0.01% |
6,898
| – | – |
|
4572
Hyster-Yale Materials Handling
HY
$675M
| $149K | ﹤0.01% |
1,953
-243
| -11% | -$17.1K |
|
4573
PUT
iShares Russell 2000 Value ETF
IWN
$14.5B
| $149K | ﹤0.01% |
1,200
-1,300
| -52% | -$153K |
|
4574
Movado Group
MOV
$841M
| $149K | ﹤0.01% |
5,308
+2,083
| +65% | +$52.9K |
|
4575
Navigator Holdings
NVGS
$1.29B
| $149K | ﹤0.01% |
13,363
+13,100
| +4,981% | +$136K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.